Report of the american Heart association (AHA) scientific sessions 2014, Chicago

Circulation Journal

Volumn 79, Issue 1, 2014, Pages 34-40

  Kohno, Takashi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

American Heart Association; Japanese Circulation Society; Late breaking clinical trials; Scientific Sessions

Indexed keywords

ACETYLSALICYLIC ACID; ALIROCUMAB; AMOXICILLIN; ATENOLOL; ATORVASTATIN; CLINDAMYCIN; CLOPIDOGREL; EDOXABAN; EZETIMIBE; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRASUGREL; SIMVASTATIN; THIENOPYRIDINE DERIVATIVE; CARDIOVASCULAR AGENT;

ACUTE CORONARY SYNDROME; ARTICLE; BACTERIAL ENDOCARDITIS; BARE METAL STENT; BIODEGRADABLE POLYMER DRUG ELUTING STENT; BLEEDING; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENTING; DEVICE APPROVAL; DRUG EFFICACY; DRUG ELUTING CARDIOVASCULAR STENT; DURABLE POLYMER DRUG ELUTING STENT; EDUCATION; EVEROLIMUS ELUTING STENT; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JAPANESE CIRCULATION SOCIETY; MARFAN SYNDROME; MEDICAL RESEARCH; MEDICAL SOCIETY; MITRAL VALVE REPAIR; MULTICENTER STUDY (TOPIC); OXYGEN THERAPY; PACLITAXEL ELUTING STENT; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAFETY; SCIENTIST; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; STENT THROMBOSIS; SYMPOSIUM; UNITED STATES; CARDIOLOGY; CARDIOVASCULAR DISEASES; HEART STROKE VOLUME; INTERNATIONAL COOPERATION; JAPAN; PATHOPHYSIOLOGY; TRENDS;

AMERICAN HEART ASSOCIATION; CARDIOLOGY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HEART FAILURE; HUMANS; INTERNATIONAL COOPERATION; JAPAN; SOCIETIES, MEDICAL; STROKE VOLUME; UNITED STATES;

EID: 84924628161     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1329     Document Type: Article

References (17)

1. Ishimori N, Kinugawa S, Yamada S, Yokoshiki H, Mitsuyama H, Tsutsui H. Report of the American Heart Association (AHA) scientific sessions 2013, Dallas. Circ J 2014; 78: 51-56.
2. Muramatsu T, Ozaki Y. European Society of Cardiology (ESC) congress report from Barcelona 2014. Circ J 2014; 78: 2610-2618.
3. Kusunose K. Report of the American College of Cardiology (ACC) Scientific Sessions 2014, Washington, DC. Circ J 2014; 78: 1311-1316.
4. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093-2104.
5. Hemmi N, Tohyama S, Nakajima K, Kanazawa H, Suzuki T, Hattori F, et al. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. Stem Cells Transl Med 2014; 3: 1473-1483.
6. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 2010; 120: 254-265.
7. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, et al; the DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014; 371: 2155-2166.
8. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al; J-Cypher Registry Investigators. Very late stent thrombosis and late target lesion revascularization after sirolimuseluting stent implantation: Five-year outcome of the J-CYPHER registry. Circulation 2012; 125: 584-591.
9. Garratt KN, Weaver WD, Jenkins RD, Pow TK, Mauri L, Kereiakes DJ, et al. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after taxus liberte paclitaxel-eluting coronary stent placement. Circulation 2014 November 16, doi:10.1161/CIRCULATIONAHA.114.013570.
10. Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, et al. Low-dose aspirin for primary prevention of cardiovascular events in japanese patients 60 years or older with atherosclerotic risk factors: A randomized clinical trial. JAMA 2014 November 17, doi:10.1001/jama.2014.15690.
11. Muhlestein JB, Lappe DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using ct angiography on mortality and cardiac events in high-risk patients with diabetes: The FACTOR-64 randomized clinical trial. JAMA 2014; 312: 2234-2243.
12. Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, et al; the Pediatric Heart Network Investigators. Atenolol versus losartan in children and young adults with marfan’s syndrome. N Engl J Med 2014; 371: 2061-2071.
13. Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, et al; the Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2014; 371: 2178-2188.
14. Kaiser C, Galatius S, Jeger R, Gilgen N, Jensen JS, Naber CK, et al. Long-term efficacy and safety of biodegradable-polymer biolimuseluting stents: Main results of the Basel Stent Kosten-Effektivitats TrialProspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Circulation 2014 November 19, doi:10.1161/CIRCULATIONAHA.114.013520.
15. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al; PARADIGM-HF Investigators and Committees. Angiotensinneprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371: 993-1004.
16. Butt M, Dwivedi G, Shantsila A, Khair OA, Lip GY. Left ventricular systolic and diastolic function in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. Circ Heart Fail 2012; 5: 226-233.
17. Yoshihisa A, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, et al. Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing. Eur J Heart Fail 2013; 15: 543-50.